Aspira Pathlab & Diagnostics Ltd - 540788 - Disclosure Under Regulation 30 Read With Regulation 31A Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Please find enclosed herewith the outcome of the Meeting of Board of Directors held on May 28, 2022 and the Minutes of the said meeting pursuant to Regulation 31A of the SEBI (LODR) Regulations, 2015, regarding Reclassification of Promoters. Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement Under Regulation 30 (LODR)-Intimation Of Updated Contact Details Of The Authorised Persons For The Purpose Of Determining The Materiality Of Any Event Or Transaction Or Information.
Pursuant to Regulation 30(5) of the Securities Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, we herein provide the updated contact details of the authorised persons for the purpose of determining the materiality of any event or transaction or information and for the purpose of making disclosure to Stock Exchange(s). Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement Under Regulation 30 (LODR)-Intimation Of Investment
Disclosure under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement Under Regulation 30 (LODR)-Re-Appointment Of Mr. Avinash Mahajan As Independent Director Of The Company
Dear Sir/Madam, Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held on Saturday, May 28, 2022 has approved the Re-appointment of Mr. Avinash Mahajan as Independent Director of the Company.The Information required to be submitted pursuant to Regulation 30 of the Listing Regulations is marked and attached as Annexure. Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement Under Regulation 30 (LODR)-Appointment Of Secretarial Auditor And Internal Auditor
Dear Sir/Madam, Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held on Saturday, May 28, 2022 has approved the appointment of M/s. Nilesh A. Pradhan & Co. LLP, Practicing Company Secretary as a Secretarial Auditor and M/s. Vishal Bhanushali & Associates, Chartered Accountant as an Internal Auditor of the Company. The Information required to be submitted pursuant to Regulation 30 of the Listing Regulations is marked and attached as 'Annexure-I & II'. Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement Under Regulation 30 (LODR)-Intimation Of Re-Appointment Of Dr. Pankaj Shah As Managing Director Of The Company
Dear Sir/Madam, Pursuant to Regulation 30 read with Part A of Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held on Saturday, May 28, 2022 has approved the appointment of Dr. Pankaj Shah as a Managing Director of the Company. The Information required to be submitted pursuant to Regulation 30 of the Listing Regulations is marked and attached as Annexure. Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday, 28 May, 2022
Pursuant to Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''''Listing Regulations''''), the Board of Directors of the Company at their held on Saturday, 28th May, 2022 which was commenced at 03:30 P.M. and concluded at 05:45 PM. Attached Agenda items were approved in the meeting. Aspira Pathlab & Diagnostics Ltd - 540788 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Dear Sir /Madam, Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Annual Secretarial Compliance Report for the financial year ended March 31, 2022 issued by Mr. Santoshkumar Pandey, Practicing Company Secretary. Kindly take the same on your record. Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Intimation for Board Meeting Intimation Under Regulation 29 Of The SEBI (LODR) Regulations, 2015 For Consideration And Approval Of The Audited Financial Results Of The Company For The Quarter And Year Ended March 31, 2022.
Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2022 ,inter alia, to consider and approve Aspira Pathlab & Diagnostics Limited has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2022 ,inter alia, to consider and approve the Audited financial results of the Company for the quarter and year ended March 31, 2022 and other matters. Aspira Pathlab & Diagnostics Ltd - 540788 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Aspira Pathlab & Diagnostics Ltd 2 CIN NO. L85100MH1973PLC289209 3 Report filed for FY 2021-2022 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* FY 2021-2022, FY 2022-2023 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) 0 8Quantum of (d), which has been met from (c)(e)* 0 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* 0 Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)FY 2020-2021, 2021-2022 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-PRIYA PANDEYDesignation :-COMPANY SECRETARY AND COMPLIANCE OFFICER Name of the Chief Financial Officer :- BALKRISHNA TALAWADEKAR Designation : -CHIEF FINANCIAL OFFICER Date: 14/05/2022